In tumors, CCRL2 is actively involved in the NK-mediated lung immune surveillance in mouse models of lung cancer [15,17] and has been also reported to be a novel marker for aged TAN (tumor-associated neutrophils) from NSCLC (non-small cell lung cancer) patients [46]. This evidence concerns the gene CCRL2 and lung cancer.